The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Co-amoxiclav 875mg/125mg Film-coated Tablets

875 mg/125 milligram(s) Film-coated tablet

Brown & Burk IR LimitedPA23148/004/003

Main Information

Trade NameCo-amoxiclav 875mg/125mg Film-coated Tablets
Active SubstancesAmoxicillin (as amoxicillin trihydrate)
Clavulanic acid (as potassium clavulanate, diluted with microcrystalline cellulose (1:1))
Strength875 mg/125 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderBrown & Burk IR Limited
Licence NumberPA23148/004/003

Group Information

ATC CodeJ01CA Penicillins with extended spectrum
J01CA04 amoxicillin


Licence Issued09/03/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0037-072-003
Interchangeable List DocumentPDF of Interchangeable List
« Back